当前位置:首页 - 行情中心 - 九洲药业(603456) - 财务分析 - 现金流量表

九洲药业

(603456)

  

流通市值:184.38亿  总市值:184.38亿
流通股本:8.89亿   总股本:8.89亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金4,275,489,879.132,801,518,807.611,307,660,128.524,374,804,746.48
  收到的税费返还208,725,713124,908,656.3462,001,960.38364,683,646.39
  收到其他与经营活动有关的现金241,355,825.98192,680,720.66156,249,280.2266,162,063.77
  经营活动现金流入小计4,725,571,418.113,119,108,184.611,525,911,369.15,005,650,456.64
  购买商品、接受劳务支付的现金2,111,258,852.371,365,765,212.56679,377,437.22,402,832,843.9
  支付给职工以及为职工支付的现金717,342,209.16495,084,704.81282,203,478.06907,508,162.91
  支付的各项税费303,744,471.69219,489,280105,463,911.62282,601,122.8
  支付其他与经营活动有关的现金251,220,845.4193,620,842.63173,193,285.98421,053,152.96
  经营活动现金流出小计3,383,566,378.622,273,960,0401,240,238,112.864,013,995,282.57
  经营活动产生的现金流量净额1,342,005,039.49845,148,144.61285,673,256.24991,655,174.07
二、投资活动产生的现金流量:
  收回投资收到的现金2,769,230.772,769,230.772,153,846.1519,600,000
  取得投资收益收到的现金---2,657,168.84
  处置固定资产、无形资产和其他长期资产收回的现金净额3,053,684.761,980,400.04405,476.25,532,253.77
  收到的其他与投资活动有关的现金---4,849,440.12
  投资活动现金流入小计5,822,915.534,749,630.812,559,322.3532,638,862.73
  购建固定资产、无形资产和其他长期资产支付的现金434,459,528.27287,285,184.8177,560,791.29888,964,773.75
  投资支付的现金100,000,000100,000,000-25,000,000
  支付其他与投资活动有关的现金--100,000,000-
  投资活动现金流出小计534,459,528.27387,285,184.8277,560,791.29913,964,773.75
  投资活动产生的现金流量净额-528,636,612.74-382,535,553.99-275,001,468.94-881,325,911.02
三、筹资活动产生的现金流量:
  取得借款收到的现金470,000,000300,000,000300,000,0001,627,052,534.16
  收到其他与筹资活动有关的现金---300,000,000
  筹资活动现金流入小计470,000,000300,000,000300,000,0001,927,052,534.16
  偿还债务支付的现金745,848,313.91295,848,313.91295,848,313.911,627,690,000
  分配股利、利润或偿付利息支付的现金453,456,095.42271,697,387.991,854,267.19471,296,198.39
  支付其他与筹资活动有关的现金106,264,596106,263,192.891,837,440437,677,761.06
  筹资活动现金流出小计1,305,569,005.33673,808,894.79299,540,021.12,536,663,959.45
  筹资活动产生的现金流量净额-835,569,005.33-373,808,894.79459,978.9-609,611,425.29
四、汇率变动对现金及现金等价物的影响-4,113,3554,568,061.654,137,864.9816,894,805.3
  现金及现金等价物净增加额平衡项目0.010.0100
五、现金及现金等价物净增加额-26,313,933.5793,371,757.4915,269,631.18-482,387,356.94
  加:期初现金及现金等价物余额2,593,681,994.962,593,681,994.962,593,681,994.963,076,069,351.9
  期末现金及现金等价物余额2,567,368,061.392,687,053,752.452,608,951,626.142,593,681,994.96
补充资料:
  净利润-526,613,903.71-607,067,516.83
  资产减值准备-40,716,046.36-218,481,518.23
  固定资产和投资性房地产折旧-182,893,221.29-359,647,619.65
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-182,893,221.29-359,647,619.65
  无形资产摊销-22,658,558.35-43,475,856.42
  长期待摊费用摊销-2,125,664.17-2,582,039.97
  处置固定资产、无形资产和其他长期资产的损失-1,859,197.68-3,156,554.9
  固定资产报废损失-426,427.23-1,978,480.76
  财务费用-6,581,031.08-5,862,553.61
  投资损失-1,839,698.01-8,132,266.51
  递延所得税-2,441,164.15--14,935,989.35
  其中:递延所得税资产减少-327,376.42--934,141.66
    递延所得税负债增加-2,113,787.73--14,001,847.69
  存货的减少-368,080,101.1--121,125,160.27
  经营性应收项目的减少--3,074,235.65--301,874,023.71
  经营性应付项目的增加--311,860,739.64-148,134,222.24
  其他-7,198,030.12-6,949,340.52
  现金的期末余额-2,687,053,752.45-2,593,681,994.96
  减:现金的期初余额-2,593,681,994.96-3,076,069,351.9
  现金及现金等价物的净增加额-93,371,757.49--482,387,356.94
公告日期2025-10-162025-08-062025-04-152025-04-11
审计意见(境内)标准无保留意见
TOP↑